NCT07069556View on ClinicalTrials.gov

ColoSense Post-Approval Study

Not yet recruitingOBSERVATIONAL

Enrollment

12,500

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

September 1, 2028

Study Completion Date

September 1, 2030

Conditions

Colorectal Cancer (Diagnosis)

Interventions

DEVICE

ColoSense

multi-target stool RNA test

Sponsors

Lead Sponsor

Geneoscopy, Inc.

All Listed Sponsors

lead

Geneoscopy, Inc.

INDUSTRY

NCT07069556 - ColoSense Post-Approval Study | Biotech Hunter | Biotech Hunter